VanEck Biotech ETF - BBH Stock Forecast, Price & News

VanEck Biotech ETF's stock was trading at $159.74 at the start of the year. Since then, BBH stock has increased by 5.1% and is now trading at $167.84.
View the best growth stocks for 2023 here.

VanEck Biotech ETF announced an annual dividend on Friday, December 16th. Investors of record on Tuesday, December 20th will be given a dividend of $0.749 per share on Friday, December 23rd. This represents a dividend yield of 0.47%. The ex-dividend date of this dividend is Monday, December 19th. This is an increase from the stock's previous annual dividend of $0.40.
Read our dividend analysis for BBH.

VanEck Biotech ETF (NASDAQ:BBH) pays an annual dividend of $0.75 per share and currently has a dividend yield of 0.45%.
Read our dividend analysis for BBH.

Based on aggregate information from My MarketBeat watchlists, some companies that other VanEck Biotech ETF investors own include Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Pfizer (PFE), Intel (INTC), Micron Technology (MU), Cidara Therapeutics (CDTX), Quest Diagnostics (DGX), Novavax (NVAX).

VanEck Biotech ETF trades on the NASDAQ under the ticker symbol "BBH."

VanEck Biotech ETF's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Conservest Capital Advisors Inc. (0.66%), Kestra Advisory Services LLC (0.58%), Bullseye Investment Management LLC (0.36%), Aspiriant LLC (0.25%), Janney Montgomery Scott LLC (0.21%) and Blue Fin Capital Inc. (0.09%).

Shares of BBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of BBH stock can currently be purchased for approximately $167.84.

VanEck Biotech ETF (NASDAQ:BBH) has a market capitalization of $532.05 million.